1. Instructions for Linking Previous CITI Training to Your NetID
  2. Human Subjects Research Protection Program (HRPP) Policy Index
  3. Instructions for Completing CITI Human Participants Research Training
  4. HRPP Newsletter - Spring 2018
  5. Human Research Protection Program Newsletter
  6. Institutional Officials in Charge of HRPP
  7. Protecting Research Participants Privacy Interests and Confidentiality of Data
  8. Engagement in Human Participants Research at UW–Madison
  9. UW–Madison Federalwide Assurance (FWA)
  10. Evaluating the Scientific or Scholarly Merits of Proposed Research
  11. Equitable Selection of Research Participants Guidance
  12. Investigating the Cause of Noncompliance and Implementing Corrective and Preventive Action (CAPA) Plans Guidance
  13. Exempt Research
  14. Certificate of Confidentiality (CoC) Application Help
  15. Continuing Review: Submission and Review
  16. Issues in Human Subjects Research When State Law May Apply
  17. Post-Approval Monitoring Program
  18. Good Clinical Practice (GCP) Training Guidance and Instructions
  19. Principal Investigator Status for UW–Madison Studies Involving Human Participants
  20. Noncompliance
  21. Human Participants Research Training
  22. Recruitment of Research Participants Guidance
  23. Review of Research Involving Vulnerable Participants
  24. HRPP Guidance, Forms and Resources
  25. Instructions for Completing CITI Refresher Training
  26. IRB Members’ Conflicts of Interest
  27. Obtaining and Documenting Informed Consent
  28. Clinical Trials Registration & Results Reporting
  29. Additional Requirements When Conducting Human Subjects Research with Environmental Protection Agency (EPA) Support
  30. Creation and Dissemination of Policies and Related Documentation
  31. Application of Federalwide Assurance (FWA) Terms to UW-Madison Human Participants Research Policy
  32. Study Closure
  33. Exempt Research (for non-federally funded, non-FDA-regulated, non-VA research)
  34. Research with Adult Participants Lacking Capacity to Consent
  35. IRB Reliance
  36. De-Identified Publicly Available Datasets Guidance
  37. IRB Composition and Quality Performance
  38. Reporting to Institutional and External Authorities
  39. Review of Data and Safety Monitoring in Research
  40. Changes in Research Activities: Submission and Review
  41. Maintenance of IRB Records
  42. ED/SBS IRB Principal Investigator Responsibilities
  43. Contact Information for Reporting Suggestions and Concerns
  44. Good Clinical Practice (GCP) Refresher Instructions
  45. UW HRPP Quality Assurance
  46. Cross-Campus Human Research Protection Program (HRPP) Committee Charter
  47. Office for Human Research Protections (OHRP) - IRB Knowledge of Local Research Context
  48. IRB Review of Study Resources
  49. Retention of IRB Records
  50. Developing an Internal Quality Assurance (QA) Program Guidance
  51. OHRP & FDA Expedited Review Guidance
  52. OHRP Guidance on Engagement of Institutions in Human Subjects Research
  53. IRB Meetings
  54. Compliance with Human Research Protections in Sponsored Research
  55. HRPP and IRB Resources
  56. Single Institutional Review Board (IRB) for Multi-Site Federal Grants Policy
  57. Reporting of Suggestions and Concerns Regarding the Protection of Research Participants
  58. IRB Consultants Use and Conflict of Interest
  59. Unanticipated Problems
  60. Considerations for Accepting or Ceding IRB Review Guidance
  61. Expert Review
  62. Monitoring the Consent Process
  63. UW-Madison HIPAA Program
  64. Campus IT Policies
  65. OPRR Guidance on 45 CFR 46.101(b)(5): Exemption for Research and Demonstration Projects on Public Benefit and Service Programs
  66. HRPP Resources for the Public
  67. Reporting of Suggestions and Concerns Regarding HRPP Performance and Function
  68. Exceptions to Informed Consent Requirements in Emergency Situations
  69. List of Approved De-Identified Publicly Available Datasets
  70. Conflicts of Interest of Non-UW-Madison Key Personnel
  71. NIH Genomic Data Sharing Policy for Human Data Guidance
  72. Initial Review: Submission and Review Policy
  73. FDA IRB Regulations (21 CFR 56)
  74. Use of Human Fetal Tissue in Research
  75. IRB Meeting Minutes and Regulatory Documentation
  76. Use of Human Fetal Tissue in Research Policy Links
  77. Student Research
  78. Compliance Monitoring and Quality Improvement
  79. IRB Analysis of Risks and Benefits of Research Guidance
  80. ED/SBS IRB Office Guidance Index
  81. Suspension and Termination of Approved Research
  82. Reportable Abuse and Neglect Guidance
  83. OHRP Continuing Review Guidance
  84. Common Rule (45 CFR 46)
  85. HRPP Education and Training
  86. IRB Authority and Independence
  87. IRB Purview
  88. Preventing Noncompliance Guidance
  89. Quality Assurance Committees
  90. Post Approval Monitoring Program Services
  91. UW Post-Approval Monitors
  92. Additional Requirements When Conducting Human Subjects Research with Department of Energy (DOE) Support
  93. Additional Requirements When Conducting Human Subjects Research with Department of Defense (DOD) Support
  94. Human Research Protection Program (HRPP) Newsletter - Spring 2017
  95. Human Research Protection Program (HRPP) Newsletter - Fall 2016
  96. Human Research Protection Program (HRPP) Newsletter - Spring 2016
  97. Additional Requirements When Conducting Human Subjects Research with Department of Justice (DOJ) Support
  98. Additional Requirements When Conducting Human Subjects Research with Department of Education (ED) Support
  99. UW Human Research Protection Program Newsletter - Fall 2015